Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 1;180(5):386-394.
doi: 10.1176/appi.ajp.20220312. Epub 2023 Mar 9.

Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder

Laura Brandt  1 , Mei-Chen Hu  1 , Ying Liu  1 , Felipe Castillo  1 , Gabriel J Odom  1 , Raymond R Balise  1 , Daniel J Feaster  1 , Edward V Nunes  1 , Sean X Luo  1
Affiliations

Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder

Laura Brandt et al. Am J Psychiatry. .

Abstract

Objective: Overdose risk during a course of treatment with medication for opioid use disorder (MOUD) has not been clearly delineated. The authors sought to address this gap by leveraging a new data set from three large pragmatic clinical trials of MOUD.

Methods: Adverse event logs, including overdose events, from the three trials (N=2,199) were harmonized, and the overall risk of having an overdose event in the 24 weeks after randomization was compared for each study arm (one methadone, one naltrexone, and three buprenorphine groups), using survival analysis with time-dependent Cox proportional hazard models.

Results: By week 24, 39 participants had ≥1 overdose event. The observed frequency of having an overdose event was 15 (5.30%) among 283 patients assigned to naltrexone, eight (1.51%) among 529 patients assigned to methadone, and 16 (1.15%) among 1,387 patients assigned to buprenorphine. Notably, 27.9% of patients assigned to extended-release naltrexone never initiated the medication, and their overdose rate was 8.9% (7/79), compared with 3.9% (8/204) among those who initiated naltrexone. Controlling for sociodemographic and time-varying medication adherence variables and baseline substance use, a proportional hazard model did not show a significant effect of naltrexone assignment. Significantly higher probabilities of experiencing an overdose event were observed among patients with baseline benzodiazepine use (hazard ratio=3.36, 95% CI=1.76, 6.42) and those who either were never inducted on their assigned study medication (hazard ratio=6.64, 95% CI=2.12, 19.54) or stopped their medication after initial induction (hazard ratio=4.04, 95% CI=1.54, 10.65).

Conclusions: Among patients with opioid use disorder seeking medication treatment, the risk of overdose events over the next 24 weeks is elevated among those who fail to initiate or discontinue medication and those who report benzodiazepine use at baseline.

Keywords: Addiction Psychiatry; Medication-Assisted Treatment; Opioids; Substance-Related and Addictive Disorders.

PubMed Disclaimer

Conflict of interest statement

The other authors report no financial relationships with commercial interests.

Comment in

References

    1. Bohnert ASB, Valenstein M, Bair MJ, et al. : Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305:1315–1321 - PubMed
    1. Mattson CL, Tanz LJ, Quinn K, et al. : Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb Mortal Wkly Rep 2021; 70:202–207 - PMC - PubMed
    1. Centers for Disease Control and Prevention: Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011; 60:1487–1492 - PubMed
    1. Jones CM, Logan J, Gladden RM, et al. : Vital signs: demographic and substance use trends among heroin users—United States, 2002–2013. MMWR Morb Mortal Wkly Rep 2015; 64:719–725 - PMC - PubMed
    1. O’Donnell JK, Gladden RM, Seth P: Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region—United States, 2006–2015. MMWR Morb Mortal Wkly Rep 2017; 66:897–903 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources